A detailed history of Panagora Asset Management Inc transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 46,781 shares of VNDA stock, worth $218,935. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46,781
Previous 60,434 22.59%
Holding current value
$218,935
Previous $341,000 35.78%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$4.61 - $6.34 $62,940 - $86,560
-13,653 Reduced 22.59%
46,781 $219,000
Q2 2024

Jul 29, 2024

BUY
$3.91 - $6.5 $9,810 - $16,308
2,509 Added 4.33%
60,434 $341,000
Q1 2024

May 07, 2024

BUY
$3.47 - $4.61 $811 - $1,078
234 Added 0.41%
57,925 $238,000
Q4 2023

Feb 08, 2024

BUY
$3.38 - $4.58 $1,534 - $2,079
454 Added 0.79%
57,691 $243,000
Q3 2023

Oct 31, 2023

BUY
$4.28 - $6.57 $582 - $893
136 Added 0.24%
57,237 $247,000
Q2 2023

Aug 11, 2023

SELL
$5.9 - $6.95 $749,559 - $882,955
-127,044 Reduced 68.99%
57,101 $376,000
Q1 2023

May 11, 2023

SELL
$6.18 - $7.99 $675,461 - $873,291
-109,298 Reduced 37.25%
184,145 $1.25 Million
Q4 2022

Feb 13, 2023

BUY
$6.87 - $10.96 $671,082 - $1.07 Million
97,683 Added 49.9%
293,443 $2.17 Million
Q3 2022

Nov 14, 2022

BUY
$9.44 - $11.76 $735,187 - $915,868
77,880 Added 66.07%
195,760 $1.93 Million
Q2 2022

Aug 15, 2022

BUY
$9.31 - $11.84 $664,259 - $844,772
71,349 Added 153.34%
117,880 $1.29 Million
Q1 2022

May 12, 2022

BUY
$10.84 - $16.55 $104,519 - $159,575
9,642 Added 26.14%
46,531 $526,000
Q2 2021

Aug 11, 2021

BUY
$15.71 - $21.51 $536,182 - $734,136
34,130 Added 1237.04%
36,889 $793,000
Q1 2021

May 12, 2021

SELL
$13.42 - $20.28 $912,640 - $1.38 Million
-68,006 Reduced 96.1%
2,759 $41,000
Q4 2020

Feb 10, 2021

BUY
$9.77 - $13.81 $322 - $455
33 Added 0.05%
70,765 $930,000
Q3 2020

Nov 13, 2020

BUY
$9.32 - $12.02 $25,406 - $32,766
2,726 Added 4.01%
70,732 $683,000
Q2 2020

Aug 12, 2020

SELL
$9.66 - $12.02 $885,474 - $1.1 Million
-91,664 Reduced 57.41%
68,006 $778,000
Q1 2020

May 14, 2020

SELL
$7.5 - $16.8 $3.03 Million - $6.79 Million
-404,125 Reduced 71.68%
159,670 $1.65 Million
Q4 2019

Feb 12, 2020

BUY
$12.38 - $17.47 $1.52 Million - $2.14 Million
122,616 Added 27.79%
563,795 $9.25 Million
Q3 2019

Nov 12, 2019

SELL
$12.27 - $15.79 $355,130 - $457,009
-28,943 Reduced 6.16%
441,179 $5.86 Million
Q2 2019

Aug 09, 2019

BUY
$13.37 - $18.85 $700,481 - $987,589
52,392 Added 12.54%
470,122 $6.62 Million
Q1 2019

May 15, 2019

SELL
$17.59 - $31.05 $30,413 - $53,685
-1,729 Reduced 0.41%
417,730 $7.69 Million
Q4 2018

Feb 14, 2019

SELL
$18.97 - $31.47 $201,726 - $334,651
-10,634 Reduced 2.47%
419,459 $11 Million
Q3 2018

Nov 13, 2018

BUY
$18.25 - $23.0 $1.9 Million - $2.39 Million
103,955 Added 31.87%
430,093 $9.87 Million
Q2 2018

Aug 14, 2018

BUY
$13.95 - $19.15 $685,251 - $940,686
49,122 Added 17.73%
326,138 $6.21 Million
Q1 2018

May 15, 2018

BUY
$14.05 - $20.2 $119,172 - $171,336
8,482 Added 3.16%
277,016 $4.67 Million
Q4 2017

Feb 14, 2018

BUY
$12.85 - $18.1 $499,312 - $703,311
38,857 Added 16.92%
268,534 $4.08 Million
Q3 2017

Nov 14, 2017

BUY
$15.4 - $18.85 $3.54 Million - $4.33 Million
229,677
229,677 $4.11 Million

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $265M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.